Skip to content

Zantac Recall Cancelled

June 23, 2021

From the WebMD website

A 2016 study that found a link between the active ingredient in the heartburn drug Zantac and cancer, leading to its eventual recall, has been retracted.

Continue reading

Earlier Retiree News post on the Zantac recall:

January 12, 2020: The FDA Announces Two More Antacid Recalls Due to Cancer Risk

September 20, 2019: Heartburn Drug Zantac May Contain Small Amounts of Known Carcinogen, FDA Says

From → Health & Safety

Comments are closed.